Skip to main content
Journal of Cerebral Blood Flow & Metabolism logoLink to Journal of Cerebral Blood Flow & Metabolism
editorial
. 2019 Apr 1;39(4):571–572. doi: 10.1177/0271678X18775811

Neurovascular origin of primary headaches

Messoud Ashina 1,, Cenk Ayata 2
PMCID: PMC6446421  PMID: 30929598

This special issue is dedicated to neurovascular mechanisms in primary headaches. Primary headaches are recurrent headaches not caused by underlying disease or structural problems.1 Migraine with or without aura affects 10% of world population and is by far the most common primary headache type in patients referred to neurologists.2,3 Cluster headache occurs much less commonly and has unique features such circadian and circannual rhythmicity unlike any other primary headache.4

For more than 100 years, and particularly after the first report by Ray and Wolff5 in humans demonstrating that focal head pain may be elicited from both extra- and intracranial vessels, there has been an intense debate whether migraine and cluster headache are neurogenic or vascular in origin.6 All substances that can induce migraine and cluster headache are vasodilators, but the causal relationship between experimentally induced attacks and vasodilatation has not been fully clarified.7 Several studies have focused on the investigation of cerebral hemodynamics using different methods and headache provocation models using pharmacological triggers. The discovery of triptans8 and CGRP antagonists9 have revolutionized our understanding of the mechanisms underlying primary headaches and demonstrated the importance of neurovascular mechanisms in drug development.

Collectively, these data have led to a more integrated “neurovascular” theory that involves both vascular and neuronal components in pathophysiology of primary headaches.6

The collection of review articles and original research papers in this special Headache issue provides both an introduction for the uninitiated and an update for the well versed on neurovascular mechanisms in primary headache, with a critical review of different methods used to investigate neurovascular mechanisms. The review articles by Hansen et al.10 and Hoffman et al.11 provide a comprehensive overview of the evidence for the neurovascular basis of migraine and cluster headaches, while Frederiksen et al.12 put perivascular innervation and its role in the regulation of cerebral blood flow in the context of primary headaches. Reviews by Chong et al.13 and Schytz et al.14 cover cutting-edge application of MRI and optical imaging technologies in selected headache disorders. Last but not the least, original articles by expert groups connect several molecular mediators (e.g. RAMP1, CGRP, KATP) and physiological processes (central trigeminovascular projections, spreading depression) to neurovascular headaches.1520

Altogether our aim is to raise awareness for headache as a neurovascular disorder with mechanisms no less complex or fascinating than other neurovascular disorders such as stroke and brain injury.

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

References

  • 1.Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edn. Cephalalgia 2018; 38: 1–211. [DOI] [PubMed]
  • 2.Rasmussen BK, Jensen R, Schroll M, et al. Epidemiology of headache in a general population – a prevalence study. J Clin Epidemiol 1991; 44: 1147–1157. [DOI] [PubMed] [Google Scholar]
  • 3.GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1545–1602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Russell MB. Epidemiology and genetics of cluster headache. Lancet Neurol 2004; 3: 279–283. [DOI] [PubMed] [Google Scholar]
  • 5.Ray BS, Wolff HG. Experimental studies on headache pain. Pain-sensitive structures of the head and their significance in headache. Arch Surg 1940; 41: 813–856. [Google Scholar]
  • 6.Olesen J, Burstein R, Ashina M, et al. Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol 2009; 8: 679–690. [DOI] [PubMed] [Google Scholar]
  • 7.Ashina M, Hansen JM, Á Dunga BO, et al. Human models of migraine-short-term pain for long-term gain. Nat Rev Neurol 2017; 13: 713–724. [DOI] [PubMed] [Google Scholar]
  • 8.Doenicke A, Brand J, Perrin VL. Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine. Lancet 1988; 1: 1309–1311. [DOI] [PubMed] [Google Scholar]
  • 9.Olesen J, Diener HC, Husstedt IW, et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004; 350: 1104–1110. [DOI] [PubMed] [Google Scholar]
  • 10.Hansen JM and Schankin CJ. Cerebral hemodynamics in the different phases of migraine and cluster headache. J Cereb Blood Flow Metab 2019; 39: 595–609. [DOI] [PMC free article] [PubMed]
  • 11.Hoffmann J, Baca SM and Akerman S. Neurovascular mechanisms of migraine and cluster headache. J Cereb Blood Flow Metab 2019; 39: 573–594. [DOI] [PMC free article] [PubMed]
  • 12.Frederiksen SD, Haanes KA, Warfvinge K, et al. Perivascular neurotransmitters: regulation of cerebral blood flow and role in primary headaches. J Cereb Blood Flow Metab 2019; 39: 610–632. [DOI] [PMC free article] [PubMed]
  • 13.Chong CD, Schwedt TJ and Hougaard A. Brain functional connectivity in headache disorders: a narrative review of MRI investigations. J Cereb Blood Flow Metab 2019; 39: 650–669. [DOI] [PMC free article] [PubMed]
  • 14.Schytz HW, Amin FM, Selb J, et al. Non-invasive methods for measuring vascular changes in neurovascular headaches. J Cereb Blood Flow Metab 2019; 39: 633–649. [DOI] [PMC free article] [PubMed]
  • 15.Sabharwal R, Mason BN, Kuburas A, et al. Increased receptor activity-modifying protein 1 in the nervous system is sufficient to protect against autonomic dysregulation and hypertension. J Cereb Blood Flow Metab 2019; 39: 690–703. [DOI] [PMC free article] [PubMed]
  • 16.Syed AU, Koide M, Brayden JE, et al. Tonic regulation of middle meningeal artery diameter by ATP-sensitive potassium channels. J Cereb Blood Flow Metab 2019; 39: 670–679. [DOI] [PMC free article] [PubMed]
  • 17.Chan KY, Labastida-Ramírez A, Ramírez-Rosas MB, et al. Trigeminovascular calcitonin gene-related peptide function in Cacna1a R192Q-mutated knock-in mice. J Cereb Blood Flow Metab 2019; 39: 718–729. [DOI] [PMC free article] [PubMed]
  • 18.Mehnert J and May A. Functional and structural alterations in the migraine cerebellum. J Cereb Blood Flow Metab 2019; 39: 730–739. [DOI] [PMC free article] [PubMed]
  • 19.Arngrim N, Hougaard A, Schytz HW, et al. Effect of hypoxia on BOLD fMRI response and total cerebral blood flow in migraine with aura patients. J Cereb Blood Flow Metab 2019; 39: 680–689. [DOI] [PMC free article] [PubMed]
  • 20.Yalcin N, Chen S-P, Yu ES, et al. Caffeine does not affect susceptibility to cortical spreading depolarization in mice. J Cereb Blood Flow Metab 2019; 39: 740–750. [DOI] [PMC free article] [PubMed]

Articles from Journal of Cerebral Blood Flow & Metabolism are provided here courtesy of SAGE Publications

RESOURCES